CAS: 864814-88-0 - Resminostat
Fórmula:C16H19N3O4S
InChI:InChI=1S/C16H19N3O4S/c1-18(2)11-13-3-6-15(7-4-13)24(22,23)19-10-9-14(12-19)5-8-16(20)17-21/h3-10,12,21H,11H2,1-2H3,(H,17,20)/b8-5+
Chave InChI:InChIKey=FECGNJPYVFEKOD-VMPITWQZSA-N
SMILES:O=C(C=CC=1C=CN(C1)S(=O)(=O)C2=CC=C(C=C2)CN(C)C)NO
- Sinónimos:
- (E)-3-[1-[[4-[(Dimethylamino)methyl]benzene]sulfonyl]-1H-pyrrol-3-yl]-N-hydroxyacrylamide
- 4SC 201
- (2E)-3-[1-[[4-[(Dimethylamino)methyl]phenyl]sulfonyl]-1H-pyrrol-3-yl]-N-hydroxy-2-propenamide
- Resminostat
- 2-Propenamide, 3-[1-[[4-[(dimethylamino)methyl]phenyl]sulfonyl]-1H-pyrrol-3-yl]-N-hydroxy-, (2E)-
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | Resminostat REF: IN-DA0039T5CAS: 864814-88-0 | 98% | A consultar | Ter 10 Dez 24 |
 | Resminostat REF: 3D-FR138825CAS: 864814-88-0 | Min. 95% | A consultar | Ter 21 Jan 25 |
 | Resminostat REF: TM-T6637CAS: 864814-88-0 | 98% | 95,00 €~539,00 € | Ter 28 Jan 25 |
Ref: IN-DA0039T5
| 5mg | 195,00 € | ||
| 10mg | 490,00 € | ||
| 50mg | A consultar |
Entrega estimada em Estados Unidos, Terça-feira 10 de Dezembro de 2024
Resminostat
CAS:864814-88-0
Resminostat is a small molecule that inhibits the transcriptional co-activator, pd-l1. It has been shown …
Fórmula:
C16H19N3O4S
Pureza:
Min. 95%
Peso molecular:
349.41 g/mol
Ref: 3D-FR138825
| 1mg | A consultar | ||
| 2mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar |
Entrega estimada em Estados Unidos, Terça-feira 21 de Janeiro de 2025
Resminostat
CAS:864814-88-0
Resminostat (4SC-201) is an orally bioavailable inhibitor of histone deacetylases (HDACs) with potential antineoplastic activity.
Fórmula:
C16H19N3O4S
Pureza:
98%
Cor e Forma:
Solid
Peso molecular:
349.4
Ref: TM-T6637
| 5mg | 95,00 € | ||
| 10mg | 168,00 € | ||
| 25mg | 298,00 € | ||
| 50mg | 539,00 € | ||
| 1mL*10mM (DMSO) | 96,00 € |
Entrega estimada em Estados Unidos, Terça-feira 28 de Janeiro de 2025
